Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F S Morrison

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Laboratory and Clinical Medicine|November 1, 1974
Hemoglobin Hope (alpha 2 beta 2(136-gly-asp))-S disease: clinical and biochemical studiesM H Steinberg, J G Adams, J T Thigpen, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group studyC A Coltman, T M McDaniel, S P Balcerzak, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group studyC A Coltman, T M Coltman, S P Balcerzak, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone hydrochloride in lymphomaC A Coltman, T M McDaniel, S P Balcerzak, et al.
Acta Haematologica|January 1, 1974
Glucose-6-phosphate dehydrogenase Jackson. A new variant associated with hemolytic anemiaJ T Thigpen, M H Steinberg, E Beutler, et al.
American Journal of Hematology|August 1, 1983
Acute leukemia and infections: perspectives from a general hospitalL Balducci, J C Halbrook, S W Chapman, et al.
American Journal of Obstetrics and Gynecology|November 1, 1993
The effect of provider education on blood utilization practicesJ C Morrison, D D Sumrall, S P Chevalier, et al.
Cancer Research|May 1, 1983
Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugsC H Park, P H Wiernik, F S Morrison, et al.
Journal of Clinical Apheresis|January 1, 1991
Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell diseaseJ C Morrison, F S Morrison, R C Floyd, et al.
Cancer|December 1, 1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative StudyD R Head, K Kopecky, J M Bennett, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Laboratory and Clinical Medicine|November 1, 1974
Hemoglobin Hope (alpha 2 beta 2(136-gly-asp))-S disease: clinical and biochemical studiesM H Steinberg, J G Adams, J T Thigpen, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group studyC A Coltman, T M McDaniel, S P Balcerzak, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone in refractory nonHodgkin's lymphoma. A Southwest Oncology Group studyC A Coltman, T M Coltman, S P Balcerzak, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone hydrochloride in lymphomaC A Coltman, T M McDaniel, S P Balcerzak, et al.
Acta Haematologica|January 1, 1974
Glucose-6-phosphate dehydrogenase Jackson. A new variant associated with hemolytic anemiaJ T Thigpen, M H Steinberg, E Beutler, et al.
American Journal of Hematology|August 1, 1983
Acute leukemia and infections: perspectives from a general hospitalL Balducci, J C Halbrook, S W Chapman, et al.
American Journal of Obstetrics and Gynecology|November 1, 1993
The effect of provider education on blood utilization practicesJ C Morrison, D D Sumrall, S P Chevalier, et al.
Cancer Research|May 1, 1983
Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugsC H Park, P H Wiernik, F S Morrison, et al.
Journal of Clinical Apheresis|January 1, 1991
Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell diseaseJ C Morrison, F S Morrison, R C Floyd, et al.
Cancer|December 1, 1989
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative StudyD R Head, K Kopecky, J M Bennett, et al.
Pageof 6